C. Bingle, R. Craig, B. Swales, V. Singleton, P. Zhou et al., Exon Skipping in Mcl-1 Results in a Bcl-2 Homology Domain 3 Only Gene Product That Promotes Cell Death, Journal of Biological Chemistry, vol.275, issue.29, pp.22136-22146, 2000.
DOI : 10.1074/jbc.M909572199

R. Craig, MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis, Leukemia, vol.16, issue.4, pp.444-454, 2002.
DOI : 10.1038/sj.leu.2402416

R. Craig, E. Jabs, P. Zhou, K. Kozopas, A. Hawkins et al., Human and Mouse Chromosomal Mapping of the Myeloid Cell Leukemia-1 Gene: MCL1 Maps to Human Chromosome 1q21, a Region That Is Frequently Altered in Preneoplastic and Neoplastic Disease, Genomics, vol.23, issue.2, pp.457-463, 1994.
DOI : 10.1006/geno.1994.1523

D. Vos, J. , J. M. Tarte, K. Jasmin, C. Klein et al., JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells, British Journal of Haematology, vol.83, issue.4, pp.823-828, 2000.
DOI : 10.1073/pnas.94.13.6764

S. Derenne, B. Monia, N. Dean, J. Taylor, M. Rapp et al., Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cells, Blood, vol.100, issue.1, pp.194-199, 2002.
DOI : 10.1182/blood.V100.1.194

P. Epling-burnette, J. Liu, R. Catlett-falcone, J. Turkson, M. Oshiro et al., Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression, Journal of Clinical Investigation, vol.107, issue.3, pp.351-362, 2001.
DOI : 10.1172/JCI9940

P. Epling-burnette, B. Zhong, F. Bai, K. Jiang, R. Bailey et al., Cooperative Regulation of Mcl-1 by Janus Kinase/STAT and Phosphatidylinositol 3-Kinase Contribute to Granulocyte-Macrophage Colony-Stimulating Factor-Delayed Apoptosis in Human Neutrophils, The Journal of Immunology, vol.166, issue.12, pp.7486-7495, 2001.
DOI : 10.4049/jimmunol.166.12.7486

Z. Gu, J. Vos, C. Rebouissou, J. M. Zhang, X. Rossi et al., Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors, Leukemia, vol.14, issue.1, pp.188-197, 2000.
DOI : 10.1038/sj.leu.2401632

N. Harada, H. Hata, M. Yoshida, T. Soniki, A. Nagasaki et al., Expression of Bcl-2 family of proteins in fresh myeloma cells, Leukemia, vol.12, issue.11, pp.1817-1820, 1998.
DOI : 10.1038/sj.leu.2401168

G. Hatzivassiliou, I. Miller, J. Takizawa, N. Palanisamy, P. Rao et al., IRTA1 and IRTA2, Novel Immunoglobulin Superfamily Receptors Expressed in B Cells and Involved in Chromosome 1q21 Abnormalities in B Cell Malignancy, Immunity, vol.14, issue.3, pp.277-289, 2001.
DOI : 10.1016/S1074-7613(01)00109-1

S. Hsu, A. Kaipia, E. Mcgee, M. Lomeli, and A. Hsueh, Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members, Proceedings of the National Academy of Sciences, vol.275, issue.5302, pp.12401-12406, 1997.
DOI : 10.1126/science.275.5302.967

S. Hsu, P. Lin, and A. Hsueh, BOD (Bcl-2-Related Ovarian Death Gene) Is an Ovarian BH3 Domain-Containing Proapoptotic Bcl-2 Protein Capable of Dimerization with Diverse Antiapoptotic Bcl-2 Members, Molecular Endocrinology, vol.12, issue.9, pp.1432-1440, 1998.
DOI : 10.1210/mend.12.9.0166

M. Jourdan, D. Vos, J. Mechti, N. Klein, and B. , Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1, Cell Death and Differentiation, vol.7, issue.12, pp.1244-1252, 2000.
DOI : 10.1038/sj.cdd.4400758
URL : https://hal.archives-ouvertes.fr/inserm-00130981

Y. Keung, C. Yung, J. Wong, F. Shah, E. Cobos et al., Unusual Presentation of Multiple Myeloma with ???Jumping Translocation??? Involving 1q21, Cancer Genetics and Cytogenetics, vol.106, issue.2, pp.135-139, 1998.
DOI : 10.1016/S0165-4608(97)00316-6

B. Klein, J. M. , D. Vos, J. Mathouk, K. Tarte et al., Biology of Multiple Myeloma, Bersagel PL and Kuehl M, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00270566

A. Kuss, M. Knodel, F. Berberich-siebelt, D. Lindemann, A. Schimpl et al., A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death, European Journal of Immunology, vol.23, issue.10, pp.3077-3088, 1999.
DOI : 10.1002/(SICI)1521-4141(199910)29:10<3077::AID-IMMU3077>3.0.CO;2-R

L. Baccon, P. Leroux, D. Dascalescu, C. Duley, S. Marais et al., Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma, Genes, Chromosomes and Cancer, vol.111, issue.3, pp.250-264, 2001.
DOI : 10.1002/gcc.1189

M. Portier, G. Rajzbaum, X. Zhang, M. Attal, C. Rusalen et al., In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma, European Journal of Immunology, vol.76, issue.1, pp.1759-1762, 1991.
DOI : 10.1002/eji.1830210727

D. Puthier, R. Bataille, and M. Amiot, IL-6 up-regulates Mcl-1 in human myeloma cells through JAK???/???STAT rather than Ras???/???MAP kinase pathway, European Journal of Immunology, vol.161, issue.12, pp.3945-3950, 1999.
DOI : 10.1002/(SICI)1521-4141(199912)29:12<3945::AID-IMMU3945>3.0.CO;2-O

D. Puthier, S. Derenne, S. Barille, P. Moreau, J. Harousseau et al., Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells, British Journal of Haematology, vol.88, issue.2, pp.392-395, 1999.
DOI : 10.1083/jcb.128.6.1173

K. Shigemasa, O. Katoh, Y. Shiroyama, S. Mihara, K. Mukai et al., Increased MCL-1 Expression Is Associated with Poor Prognosis in Ovarian Carcinomas, Japanese Journal of Cancer Research, vol.16, issue.Suppl., pp.542-550, 2002.
DOI : 10.1111/j.1349-7006.2002.tb01289.x

H. Spets, H. Jernberg-wiklund, C. Sambade, O. Soderberg, and K. Nilsson, The effects on growth and survival of IL-6 can be dissociated in the U-266-1970/U-266-1984 and HL407E/HL407L human multiple myeloma cell lines, British Journal of Haematology, vol.98, issue.1, pp.126-133, 1997.
DOI : 10.1046/j.1365-2141.1997.1903004.x

S. Suematsu, T. Matsusaka, T. Matsuda, S. Ohno, J. Miyazaki et al., Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice., Proceedings of the National Academy of Sciences, vol.89, issue.1, pp.232-235, 1992.
DOI : 10.1073/pnas.89.1.232

T. Yang, K. Kozopas, and R. Craig, The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2, The Journal of Cell Biology, vol.128, issue.6, pp.1173-1184, 1995.
DOI : 10.1083/jcb.128.6.1173

B. Zhang, I. Gojo, and R. Fenton, Myeloid cell factor-1 is a critical survival factor for multiple myeloma, Blood, vol.99, issue.6, pp.1885-1893, 2002.
DOI : 10.1182/blood.V99.6.1885

P. Zhou, N. Levy, H. Xie, L. Qian, C. Lee et al., MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes, Blood, vol.97, issue.12, pp.3902-3909, 2001.
DOI : 10.1182/blood.V97.12.3902